RE:Medical Mutual ask resistance to three drugs in three classeQuote:
"Multi-drug Resistant HIV-1 Infection. Criteria.
The patient must meet the following criteria (a, b, c, d AND e):
a)The patient is at least 18 years of age; AND
b)Trogarzo is prescribed by or in consultation with an infectious diseases physician or a physician who specializes
in the treatment of HIV infections; AND
c)The patient has been diagnosed with multi-drug resistant HIV-1 infection and meets the following criteria (i and
ii):
i.Patient has been adherent to treatment with antiretrovirals for at least 6 months and are failing or recently failed therapy; AND
ii.Patient has documented resistance to at least one antiretroviral medication from each of three classes of antiretroviral medications (NRTI, NNRTI, and PI) as measured by resistance testing (i.e. genotype and phenotype) [documentation required]; AND
d)The patient has a RNA viral load greater than 1,000 copies/mL [documentation required]; AND
e)Trogarzo will be used in combination with other antiretroviral medications."
This company policy is clearly against FDA label. When HIV patients are denied of this treatment, they will sue this company to bankruptcy ! This will be a disaster waiting to happen.